SCHEMBL30755472

SCHEMBL30755472

Cc1c(C(F)(F)F)ccc(C2CCC(F)(F)CC2)c1C(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 2/20 0.35
▸ IDH2 P48735 1/20 0.35
▸ NR1H2 P55055 3/20 0.34
▸ NR1H3 Q13133 3/20 0.34
▸ RXRA P19793 1/20 0.34
▸ TP53 P04637 1/20 0.33
▸ RBP4 P02753 4/20 0.33
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ SLC9A1 P19634 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ IL1B P01584 1/20 0.32
▸ P2RX7 Q99572 1/20 0.32
▸ HSD11B1 P28845 1/20 0.32
▸ GRM6 O15303 1/20 0.32
▸ SCN10A Q9Y5Y9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30755433 0.86 HDAC4 (0.36) IDH1IDH2TP53MEN1KMT2A
SCHEMBL27379299 0.86 HDAC4 (0.36) IDH1IDH2TP53MEN1KMT2A
SCHEMBL30755526 0.85 NR1H2 (0.34) IDH1IDH2NR1H2NR1H3RXRA
SCHEMBL27379106 0.85 NR1H2 (0.34) IDH1IDH2NR1H2NR1H3RXRA
SCHEMBL27379394 0.85 HSD11B1 (0.39) TP53MEN1KMT2AATMIL1B
SCHEMBL27378973 0.82 MEN1 (0.38) IDH1IDH2CYP3A4CYP2C9CYP2C19
SCHEMBL30755212 0.80 CA12 (0.37) IDH1IDH2MEN1KMT2AATM
SCHEMBL27375857 0.80 MEN1 (0.36) IDH1IDH2NR1H2TP53MEN1
SCHEMBL27375885 0.80 CA12 (0.37) IDH1IDH2MEN1KMT2AATM
SCHEMBL27379265 0.79 MEN1 (0.33) CYP2C9CYP2C19MEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4562016-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 — — EP disclosed
WO-2024026483-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback